Lifting of Avastin conditions sets stage for wider colorectal use in Japan
This article was originally published in Scrip
Executive Summary
The conditional approval restrictions applied in Japan to Chugai/Roche's Avastin (bevacizumab) in colorectal cancer have been lifted, clearing the way for wider uptake of the anti-VEGF antibody.